Table 2 Pre- and post-radiotherapy findings of studied patients compared with healthy levels
Parameters | HD | Pre | Post | P 1 | P 2 | OR | 95%CI |
|---|---|---|---|---|---|---|---|
N (106/ml) | 3.30 (2.00–5.90) | 3.90 (1.70–13.20) | 3.31 (0.95–23.49) | 0.06 | 0.03 | 0.46 | (0.18, 1.15) |
L (106/ml) | 2.05 (1.00–3.50) | 1.30 (0.20–6.00) | 0.43 (0.12–2.32) | 0.00 | 0.00 | 29.71 | (3.68, 239.94) |
NLR (106/ml) | 1.60 (0.90–3.30) | 2.47 (1.29–29.50) | 8.24 (1.34–68.21) | 0.00 | 0.00 | 0.19 | (0.06, 0.55) |
EBV DNA (copies/ml) | 56.11 (0.00–3213.50) | 1132.56 (0.00–19065.22) | 35.67 (0.00–5678.50) | 0.00 | 0.00 | 0.02 | (0.00, 0.20) |
CD4+ (106/ml) | 0.70 (0.18–1.20) | 0.37 (0.05–1.09) | 0.07 (0.00–073) | 0.00 | 0.00 | 9.50 | (2.81, 32.10) |
Treg (106/ml) | 0.08 (0.04–0.23) | 0.09 (0.01–0.26) | 0.02 (0.00–0.16) | 0.68 | 0.00 | 0.86 | (0.35, 2.10) |
CD8+ (106/ml) | 8.49 (3.02–14.85) | 3.42 (0.00–7.16) | 0.22 (0.00–0.75) | 0.00 | 0.00 | 20.06 | (4.21, 95.56) |
CD8+PD1+ (106/ml) | 0.19 (0.05–0.45) | 0.13 (0.03–0.58) | 0.05 (0.01–0.19) | 0.02 | 0.00 | 3.17 | (1.21, 8.30) |